Wednesday, October 28, 2026Eastern Time · Updated through the dayRSS

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

MH

By Maren Holt · Senior Reporter, GLP-1

Oct 28 07:45 ETSource: Business Insider

From the source

Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

Read at businessinsider.com

Source URL https://www.businessinsider.com/retatrutide-ozempic-weight-loss-comparison-side-effects-eli-lilly-results-2026-10

Prescribed peptides from $99/moSee all →